Irbesartan Overcomes Gemcitabine Resistance in Pancreatic Cancer by Suppressing Stemness and Iron Metabolism via Inhibition of the Hippo/YAP1/C-jun Axis

Scientists established a bio-bank of human pancreatic ductal adenocarcinoma (PDAC) organoid models, covering a representative range of PDAC tumor subtypes.